Optimizing Allogeneic Transplant Strategies in ALL

(7:31)

Optimizing Allogeneic Cell Therapy Manufacturing with Atara Biotherapeutics

(40:1econd)

Optimizing Your Allogeneic Therapy Supply Chain for Success

(1:34)

How to optimize donor selection for allogeneic transplant?

(9:37)

Using Clinical Pharmacology \u0026 Pharmacometrics to Accelerate CAR-T Development

(55:32)

[Dr. Daniel’s Love of My Blood] Conditioning of Allogeneic hematopoietic stem cell transplantation

(19:16)

Optimizing conditioning regimens in patients with AML undergoing alloSCT

(1:46)

Optimizing myeloablative conditioning regimens in older patients receiving alloHSCT

(3:1econd)

Autologous vs allogeneic therapy: how will this space evolve?

(1:40)

Allogeneic Stem Cell Transplant in Acute Lymphoblastic Leukemia

(4:58)

Allogeneic Transplant - Late effects of transplant (Part 4)

(1:20:45)

CAR-T Cells: Poseida Therapeutics - Matt Spear

(12:51)

Allogeneic stem cell transplantation for older patients: where do we stand?

(1:4:39)

Allogeneic T cell therapies

(28:7)

Allogeneic Cell Therapies Summit May 2021 | Dr. Ezequiel Zylberberg

(29:48)

Need for Infection Control in Patients Receiving High-Dose Therapy and Allogeneic Transplant

(6:51)

Optimizing outcomes with pre- and post-transplant interventions

(2:38)

Need for Infection Control in Patients Receiving High-Dose Therapy and Allogeneic Transplant

(6:52)